The University of Tasmania is set to become a world leader in pharmaceutical research, with the opening today of a $4.6 million analytical research centre.
The centre is a joint project of the university and pharmaceutical giant Pfizer, to facilitate collaborative research between the State's top chemists, and leaders in the pharmaceutical industry.
Professor Paul Haddad will head the centre, and he says it's an exciting expansion for the University.
"Primarily it's a collaboration with the largest drug company in the world, and it allows us to expand a lot of our activities, and basically it's moving us into an area that up until now we hadn't been working strongly in," he said.
Commitment is not a piece of cake~ - We all want to be in a relationship at one point in our lives, but do we ever really stop and think about the true meaning of the responsibility of committ...
4 days ago